Wednesday, November 28, 2012

• Best Biotechnology and Pharmaceutical Investing Interviews of 2012: Opportunities in Oncology Treatments Create Stock Market WinnersWall Street Transcript (Wed, Nov 28)
• Amgen Therapy Slims Monkeys as Study Seeks Obesity Drugat Bloomberg (Wed, Nov 28)
• 5 Stocks Pushing The Health Care Sector Lowerat TheStreet (Wed, Nov 28)
• Abbott's Humira's Label ExpandedZacks (Wed, Nov 28)

Tuesday, November 27, 2012

• Best Biotechnology and Pharmaceutical Investing Interviews of 2012: Institutional Investor All-America Research Team Rising Star Matthew Roden at UBS Investment BankWall Street Transcript (Tue, Nov 27)

Monday, November 26, 2012

• Amgen Dividend Hike Expected and 4 Stock Analyses Making Roundsat Wall St. Cheat Sheet (Mon, Nov 26)
• Can Map Pharma Cure Your Portfolio Headache?at Motley Fool (Mon, Nov 26)
• High Stake Search For The Next Lipitorat Seeking Alpha (Mon, Nov 26)

Saturday, November 24, 2012

• Buy, Sell, or Hold: Questcor Pharmaceuticalsat Motley Fool (Sat, Nov 24)

Friday, November 23, 2012

• Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry's Success in 2012Marketwired (Fri, Nov 23)

Wednesday, November 21, 2012

• Hot Biotechs And Possible Shorting Opportunitiesat Seeking Alpha (Wed, Nov 21)
• Choosing Between a Mixed Bag and a Defensive Investmentat Motley Fool (Wed, Nov 21)
• Therapeutic Cancer Vaccines: From The Underwhelming To The Excitingat Seeking Alpha (Wed, Nov 21)

Tuesday, November 20, 2012

• Amgen Inc Stock Buy Recommendation Reiterated (AMGN)at TheStreet (Tue, Nov 20)

Monday, November 19, 2012

• Deere, Sherwin-Williams Lead Big-Cap Growth Stocksat Investor's Business Daily (Mon, Nov 19)
• Amgen Inc (AMGN): Today's Featured Health Care Winnerat TheStreet (Mon, Nov 19)

Friday, November 16, 2012

• 3 Horrendous Health-Care Stocks This Weekat Motley Fool (Fri, Nov 16)
• What Is So Exciting About MEI Pharma?at Seeking Alpha (Fri, Nov 16)
• Biotech ETFs: A Fiscal Cliff Safe Haven?Zacks (Fri, Nov 16)
• Recent Data Presented At Melanoma Conference Offers Hope For Patients, Research For Investorsat Seeking Alpha (Fri, Nov 16)
• Cramer's Top Stock Picks: AMGN, HPY, but Avoid JCPat TheStreet (Fri, Nov 16)
• The Zacks Analyst Blog Highlights: Starbucks Corporation, Tevana Holdings, Inc., Celgene Corporation, Amgen Inc. and Pfizer Inc.Zacks (Fri, Nov 16)

Thursday, November 15, 2012

• Cramer's 'Mad Money' Recap: All Is Not Lostat TheStreet (Thu, Nov 15)
• Is Threshold on the Threshold?at Motley Fool (Thu, Nov 15)
• [video] Life of the Party?at CNBC (Thu, Nov 15)

Add AMGN News to My Yahoo!